MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 21.560
- +0.990+4.81%
Close Dec 24 13:00 ET
- 21.560
- 0.0000.00%
Post 13:00 ET
720.48MMarket Cap-13.04P/E (TTM)
21.640High20.250Low42.41KVolume20.620Open20.570Pre Close899.12KTurnover0.42%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High2.65P/B219.91MFloat Cap15.31052wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM6.76%Amplitude15.310Historical Low21.201Avg Price1Lot Size
About MBX Biosciences Company
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Company Profile
SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com
Company Executives
- Name
- Position
- Salary
- Peter Kent Hawryluk
- President, Chief Executive Officer and Director
- 4.86M
- Dr. Salomon Azoulay, M.D.
- Chief Medical Officer
- --
- Richard B. Bartram
- Chief Financial Officer and Principal Accounting Officer
- 1.05M
- Edward T. Mathers
- Independent Director
- --
- Dr. Ora H. Pescovitz, M.D.
- Independent Director
- --
- James M. Cornelius
- Independent Director
- --
- Dr. Tiba Aynechi, PhD
- Independent Director
- --
- Dr. Steven Ryder, M.D.
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
- Patrick J. Heron
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
